1. Acknowledgement to Referees

   Acknowledgement 05 November 2019 Pages: 1149 - 1152

2. A Systematic Review of Economic Evaluations Assessing the Cost-Effectiveness of Licensed Drugs Used for Previously Treated Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) Negative Advanced/Metastatic Non-Small Cell Lung Cancer

   • Daniel Gallacher
   • Peter Auguste
   • Xavier Armoiry

   Systematic Review 03 October 2019 Pages: 1153 - 1174

   

3. Investigation of the Association Between Total and Free Plasma and Saliva Mycophenolic Acid Concentrations Following Administration of Enteric-Coated Mycophenolate Sodium in Adult Kidney Transplant Recipients

   • Emily Brooks
   • Susan E. Tett
   • Christine E. Staatz

   Original Research Article 23 August 2019 Pages: 1175 - 1184

   

4. Randomized Comparison Study of Novel Recombinant Human Antithrombin Gamma and Plasma-Derived Antithrombin in Healthy Volunteers

   • Hidetoshi Furuie
   • Hironori Kanda

   Original Research Article Open access 06 September 2019 Pages: 1185 - 1194

   

5. Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment

   • Nai-Lun Yeh
   • Che-Yuan Hsu
   • Hsien-Yi Chiu

   Original Research Article 23 September 2019 Pages: 1195 - 1203

   

6. Evaluation of the Feasibility of a Web-Based Survey to Assess Patient-Reported Symptom Improvement and Treatment Satisfaction Among Patients with Psoriatic Arthritis Receiving Secukinumab

   • Marina Magrey
   • Michael Bozyczko
   • Peter Hur

   Original Research Article Open access 23 September 2019 Pages: 1205 - 1212

   

7. Open-Label Study to Assess the Efficacy of Ipragliflozin for Reducing Insulin Dose in Patients with Type 2 Diabetes Mellitus Receiving Insulin Therapy

   • Hisamitsu Ishihara
   • Susumu Yamaguchi
   • Yoshinori Kosakai

   Original Research Article Open access 24 September 2019 Pages: 1213 - 1221

   

8. Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects

   • Dénes Csonka
   • Shirin Bruderer
   • Juan Jose Perez-Ruixo

   Original Research Article Open access 24 September 2019 Pages: 1223 - 1232

   

9. Efficacy of the Topical Calcineurin Inhibitors Tacrolimus and Pimecrolimus in the Treatment of Vitiligo in Infants Under 2 Years of Age: A Randomized, Open-Label Pilot Study

   • Wenting Hu
   • Yongping Xu
   • Ai-E Xu

   Short Communication 14 September 2019 Pages: 1233 - 1238

   

10. Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study

    • Esther Merlini
    • Federico A. Cazzaniga
    • Giulia Marchetti

    Short Communication Open access 17 September 2019 Pages: 1239 - 1249

    

11. Nivolumab-Induced Recurrence of Rheumatoid Arthritis in a Patient with Metastatic Gastric Adenocarcinoma

    • Masataka Nishikawa
    • Atsushi Goshima
    • Takeshi Fuji

    Research Letter 29 August 2019 Pages: 1251 - 1254

    

12. Non-Vitamin K Antagonist Oral Anticoagulant Treatment in Centenarians: A Series of Four Cases

    • Yuval Kuntzman
    • Eyal Zimlichman
    • Shmuel Tiosano

    Research Letter 03 September 2019 Pages: 1255 - 1258